Novavax EUA Justified By US FDA With Claims Of COVID Vaccine Supply Constraints

 
• By Derrick Gingery

The agency also includes a myocarditis warning in the fact sheet for the first protein-based COVID-19 vaccine to reach the US market.

Novavax COVID-19 vaccine
Novavax received an EUA for only a primary vaccine series, which is two shots three weeks apart. • Source: Shutterstock

More from Vaccines

More from Pink Sheet